---
figid: PMC7811327__AMS-17-1-91676-g001
figtitle: Diagram of phosphatidyl-inositol 3-kinase/serine-threonine kinase pathway
organisms:
- NA
pmcid: PMC7811327
filename: AMS-17-1-91676-g001.jpg
figlink: pmc/articles/PMC7811327/figure/f0001/
number: F1
caption: Diagram of phosphatidyl-inositol 3-kinase/serine-threonine kinase pathway.
  Receptor tyrosine kinase activates phosphatidyl-inositol 3-kinase catalytic subunit
  p110 and regulatory subunit p85 that converts phosphatidylinositol 4,5-bisphosphate
  to phosphatidylinositol 3,4,5-trisphosphate and causes serine-threonine kinase membrane
  recruitment and activation, and hence regulating transcription in the cell nucleusRTK
  – receptor tyrosine kinase, PTEN – phosphatase and tensin homologue encoded on chromosome
  10, PIP2 – phosphatidylinositol 4,5-bisphosphate, PIP3 – phosphatidylinositol 3,4,5-trisphosphate,
  PDK1 – 3-phosphoinositide-dependent kinase-1, PP2A – protein phosphatase 2, PH –
  pleckstrin homology domain, AKT – serine-threonine kinase, T308 –threonine 308 phosphorylation
  site at the AKT kinase catalytic domain, S473 – serine 473 phosphorylation site
  at the AKT kinase regulatory domain, PO4 – phosphate group, VEGF – vascular endothelial
  growth factor, p85 – regulatory domain of phosphatidyl-inositol 3-kinase, p110 –
  catalytic domain of phosphatidyl-inositol 3-kinase, PTEN – phosphatase and tensin
  homologue protein acts as a phosphatase to dephosphorylate, PIP3 – this dephosphorylation
  results in inhibition of the AKT signalling pathway.
papertitle: 'Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous
  cell carcinoma: literature review.'
reftext: Anna Starzyńska, et al. Arch Med Sci. 2021;17(1):207-217.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.95638
figid_alias: PMC7811327__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Arabidopsis thaliana
redirect_from: /figures/PMC7811327__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7811327__AMS-17-1-91676-g001.html
  '@type': Dataset
  description: Diagram of phosphatidyl-inositol 3-kinase/serine-threonine kinase pathway.
    Receptor tyrosine kinase activates phosphatidyl-inositol 3-kinase catalytic subunit
    p110 and regulatory subunit p85 that converts phosphatidylinositol 4,5-bisphosphate
    to phosphatidylinositol 3,4,5-trisphosphate and causes serine-threonine kinase
    membrane recruitment and activation, and hence regulating transcription in the
    cell nucleusRTK – receptor tyrosine kinase, PTEN – phosphatase and tensin homologue
    encoded on chromosome 10, PIP2 – phosphatidylinositol 4,5-bisphosphate, PIP3 –
    phosphatidylinositol 3,4,5-trisphosphate, PDK1 – 3-phosphoinositide-dependent
    kinase-1, PP2A – protein phosphatase 2, PH – pleckstrin homology domain, AKT –
    serine-threonine kinase, T308 –threonine 308 phosphorylation site at the AKT kinase
    catalytic domain, S473 – serine 473 phosphorylation site at the AKT kinase regulatory
    domain, PO4 – phosphate group, VEGF – vascular endothelial growth factor, p85
    – regulatory domain of phosphatidyl-inositol 3-kinase, p110 – catalytic domain
    of phosphatidyl-inositol 3-kinase, PTEN – phosphatase and tensin homologue protein
    acts as a phosphatase to dephosphorylate, PIP3 – this dephosphorylation results
    in inhibition of the AKT signalling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tie
  - Ras85D
  - InR
  - Pdk1
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - Myb
  - Pi3K21B
  - Taf5
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Pten
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - Akt
  - PDK1
  - PIP2A
  - PIP3
  - PP2A
---
